Solid Biosciences (SLDB) Stock Price, Quote, News & History | Benzinga

Solid Biosciences Inc (SLDB) Stock Price, Quote, News & History

SLDBNASDAQ

Trade with Public

Trade with Public

$8.73

0.111.28%

At close: Aug 4, 5:00 PM EST

$8.65

0.030.35%

Pre-Market: 8:03 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$8.73

Volume / Avg.

230.00 / 1.69M

Day Range

- - -

52 Wk Range

3.79 - 11.45

Market Cap

$851.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

20.65%

Days to Cover

11.18

Recent Solid Biosciences Inc News

Sophia Genetics, Ormat Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

U.S. stock futures mostly higher, Nasdaq futures gain 100+ points. Sophia Genetics (SOPH) falls after pricing public offering of $50M. Other stocks decline in pre-market.

Avi Kapoor

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

Wall Street analysts changed ratings on top stocks. For insights on changes, see analyst ratings page. RBRK stock: buy or not? Analysts weigh in.

Avi Kapoor

Solid Biosciences Touts Encouraging Results For Duchenne Gene Therapy, FDA Talks Planned

Solid Biosciences stock fell 8% after new SGT-003 Duchenne trial data. Investors remain cautious despite promising results and FDA plans.

Vandana Singh

What's Going On With Moderna, Capricor, Other Biotech Stocks On Monday?

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capricor, Moderna, and raising hopes for smoother drug approvals.

Vandana Singh

Relmada Therapeutics, Xenon Pharmaceuticals, Dianthus Therapeutics And Other Big Stocks Moving Higher On Monday

US stocks tumble as Dow falls 650 points. Relmada Therapeutics stock rises 40.8% on promising cancer treatment data. Hims & Hers and Xenon Pharma jump over 40%.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-171.67M

Investing Cash Flow (TTM)

13.77M

Financing Cash Flow (TTM)

243.75M

Free Cash Flow (TTM)

-172.86M

Capital Expenditure (TTM)

-1.19M

Net Change in Cash (TTM)

85.84M

Analyst Trends and Forecast

1

Feb

8

Mar

3

May

1

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$499.45M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.30

Earnings Yield % (TTM)

-21.99%

Earnings Yield % (FWD)

-19.70%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.80

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$588.00K

Total Cash

$297.10M

Debt to Equity

0.06

Issuance of Debt (TTM)

-$588.00K

Repayment of Debt (TTM)

-$588.00K

Key Statistics

Open

-

Close

$8.73

Volume / Avg.

230.00 / 1.69M

Day Range

- - -

52 Wk Range

3.79 - 11.45

Market Cap

$851.59M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

51

Short Interest

20.65%

Days to Cover

11.18

About

Sector

Health Care

Industry

Biotechnology

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Solid Biosciences (SLDB) stock?

A

You can purchase shares of Solid Biosciences (NASDAQ:SLDB) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Solid Biosciences (SLDB) competitors?

A

There are no as such competitors for Solid Biosciences.

Q

What is the forecast, or price target, for Solid Biosciences (SLDB) stock?

A

Solid Biosciences has a consensus price target of $16.74.

Q

What is the current price for Solid Biosciences (SLDB)?

A

The stock price for Solid Biosciences (NASDAQ: SLDB) is $8.65 last updated August 6, 2026 at 7:14 AM EDT.

Q

Does Solid Biosciences (SLDB) pay a dividend?

A

There are no upcoming dividends for Solid Biosciences.

Q

When is Solid Biosciences (NASDAQ:SLDB) reporting earnings?

A

Solid Biosciences does not have any upcoming earnings scheduled.

Q

Is Solid Biosciences (SLDB) going to split?

A

There is no upcoming split for Solid Biosciences.

Q

What sector and industry does Solid Biosciences (SLDB) operate in?

A

Solid Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.